Jacques J. M. van Dongen

49.7k citations

487 papers · 26.2k · 6 hit papers · h-index 81

Impact in

Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Immunology top 0.1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunodeficiency and Autoimmune Disorders

Papers in

Immunology 198
- Immune Cell Function and Interaction 94
- T-cell and B-cell Immunology 92
- Immunodeficiency and Autoimmune Disorders 84
Molecular Biology 117

Co-authors: Vincent H. J. van der Velden (83 shared papers)Mirjam van der Burg (69 shared papers)Anton W. Langerak (77 shared papers)Menno C. van Zelm (51 shared papers)Tomasz Szczepański (42 shared papers)Alberto Órfão (58 shared papers)Herbert Hooijkaas (35 shared papers)Frank J. T. Staal (33 shared papers)
Journals: Blood (53 papers)Leukemia (51 papers)Frontiers in Immunology (20 papers)The Journal of Immunology (19 papers)British Journal of Haematology (15 papers)
Partner nations: Netherlands Spain Germany

In The Last Decade

Jacques J. M. van Dongen

473 papers receiving 25.2k citations

Jacques J. M. van Dongen's Hit Papers

6 papers align trajectories log scale

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies 2015 · 347 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Blood
2007 Leukemia
2003 Leukemia
2003 Leukemia
2001 Journal of Clinical Oncology
1997 The Journal of Pediatrics

Peers

Countries citing papers authored by Jacques J. M. van Dongen

Since Specialization

Citations

This map shows the geographic impact of Jacques J. M. van Dongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques J. M. van Dongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques J. M. van Dongen more than expected).

Fields of papers citing papers by Jacques J. M. van Dongen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques J. M. van Dongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques J. M. van Dongen. The network helps show where Jacques J. M. van Dongen may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacques J. M. van Dongen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacques J. M. van Dongen Line = papers co-authored together Jacques J. M. van Dongen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 487 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program Leukemia ·J Gäbert, Emmanuel Beillard, Vincent H. J. van der Velden, W Bi, David Grimwade, Niels Pallisgaard, Gisela Barbany, Giovanni Cazzaniga, J M Cayuela, Hélène Cavé, Fabrizio Pane, Joeri L. Aerts, Daniela De Micheli, Xavier Thirion, Vincent Pradel, Marcos González, Susanne Viehmann, M Malec, Giuseppe Saglio, Jacques J. M. van Dongen Hit paper breakdown →	2003	1138
2	Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse Journal of Clinical Oncology ·Eric L. Sievers, Richard A. Larson, Edward A. Stadtmauer, Elihu H. Estey, Bob Löwenberg, Hervé Dombret, Chatchada Karanes, Matthias Theobald, John M. Bennett, Matthew L. Sherman, Mark S. Berger, Catharine B. Eten, Michael R. Loken, Jacques J. M. van Dongen, Irwin D. Bernstein, Frederick R. Appelbaum, (unknown) Hit paper breakdown →	2001	707
3	Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program Leukemia ·Emmanuel Beillard, Niels Pallisgaard, Vincent H. J. van der Velden, W Bi, Rob Dee, C. Ellen van der Schoot, Éric Delabesse, Elizabeth Macintyre, Enrico Gottardi, Giuseppe Saglio, Franz Watzinger, Thomas Lion, Jacques J. M. van Dongen, Peter Hokland, J Gäbert Hit paper breakdown →	2003	678
4	Immunophenotyping of blood lymphocytes in childhoodReference values for lymphocyte subpopulations The Journal of Pediatrics ·W M Comans-Bitter, Ronald de Groot, René van den Beemd, Herman J. Neijens, Wim C.J. Hop, K Groeneveld, Herbert Hooijkaas, Jacques J. M. van Dongen Hit paper breakdown →	1997	584
5	Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data Leukemia ·Vincent H. J. van der Velden, Giovanni Cazzaniga, André Schrauder, Jeremy Hancock, Peter Bader, E. Renate Panzer-Grümayer, T Flohr, Rosemary Sutton, Hélène Cavé, Hans O. Madsen, J M Cayuela, Jan Trka, Cornelia Eckert, Letizia Foroni, Udo zur Stadt, Kheïra Beldjord, Thorsten Raff, C. Ellen van der Schoot, Jacques J. M. van Dongen, (unknown) Hit paper breakdown →	2007	491
6	Proposals for immunological classification of acute leukemias. PubMed ·Jacques J. M. van Dongen	1995	446
7	An Antibody-Deficiency Syndrome Due to Mutations in theCD19Gene New England Journal of Medicine ·Menno C. van Zelm, İsmail Reisli, Mirjam van der Burg, Diana Castaño, Carel J.M. van Noesel, Maarten J. D. van Tol, Cristina Woellner, Bodo Grimbacher, Pablo Javier Patiño Grajales, Jacques J. M. van Dongen, José Luis Franco	2006	434
8	Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects Leukemia ·Vincent H. J. van der Velden, Andreas Hochhaus, Giovanni Cazzaniga, Tomasz Szczepański, J Gäbert, Jacques J. M. van Dongen	2003	410
9	Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence Cancer ·Richard A. Larson, Eric L. Sievers, Edward A. Stadtmauer, Bob Löwenberg, Elihu H. Estey, Hervé Dombret, Matthias Theobald, D. Voliotis, John M. Bennett, Maria Richie, Lance Leopold, Mark S. Berger, Matthew L. Sherman, Michael R. Loken, Jacques J. M. van Dongen, Irwin D. Bernstein, Frederick R. Appelbaum, (unknown)	2005	347
10	Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies Blood ·Jacques J. M. van Dongen, Vincent H. J. van der Velden, Monika Brüggemann, Alberto Órfão Hit paper breakdown →	2015	347
11	Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection Nature Medicine ·Mette D. Hazenberg, Sigrid A. Otto, J. W. T. Cohen Stuart, Martie C. M. Verschuren, Jan C.C. Borleffs, Charles A. Boucher, Roel A. Coutinho, Joep M. A. Lange, Tobias F. Rinke de Wit, Aster Tsegaye, Jacques J. M. van Dongen, Dörte Hamann, Rob J. de Boer, Frank Miedema	2000	336
12	CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency Journal of Clinical Investigation ·Menno C. van Zelm, Julie Smet, Brigitte Adams, Françoise Mascart, Liliane Schandené, Françoise Janssen, Alina Ferster, Chiung-Chi Kuo, Shoshana Levy, Jacques J. M. van Dongen, Mirjam van der Burg	2010	297
13	Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells Blood ·Vincent H. J. van der Velden, Jeroen G. te Marvelde, Patricia G. Hoogeveen, Irwin D. Bernstein, Adriaan B. Houtsmuller, Mark S. Berger, Jacques J. M. van Dongen	2001	288
14	Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways Blood ·Magdalena A. Berkowska, Gertjan J. Driessen, Vasilis Bikos, Christina Großerichter-Wagener, Κώστας Σταματόπουλος, Andrea Cerutti, Bing He, Katharina Biermann, Johan F. Lange, Mirjam van der Burg, Jacques J. M. van Dongen, Menno C. van Zelm	2011	275
15	Circulating CD21 ^low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells Proceedings of the National Academy of Sciences ·Mirzokhid Rakhmanov, Baerbel Keller, Sylvia Gutenberger, Christian Foerster, Manfred Hoenig, Gertjan J. Driessen, Mirjam van der Burg, Jacques J. M. van Dongen, Elisabeth Wiech, Marcella Visentini, Isabella Quinti, Antje Prasse, Nadine Voelxen, Ulrich Salzer, Sigune Goldacker, Paul Fisch, Hermann Eibel, Klaus Schwarz, Hans‐Hartmut Peter, Klaus Warnatz	2009	270
16	Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia Leukemia ·T Flohr, André Schrauder, Giovanni Cazzaniga, R Panzer-Grümayer, Vincent van der Velden, Susanna Fischer, Martin Stanulla, Giuseppe Basso, Felix Niggli, Beat W. Schäfer, Rosemary Sutton, Rolf Koehler, M Zimmermann, Maria Grazia Valsecchi, Helmut Gadner, Giuseppe Masera, Martin Schrappe, Jacques J. M. van Dongen, Andrea Biondi, Claus R. Bartram, (unknown)	2008	263
17	T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation Journal of Molecular Medicine ·Mette D. Hazenberg, Martie C. M. Verschuren, Dörte Hamann, Frank Miedema, Jacques J. M. van Dongen	2001	257
18	Canonical Wnt Signaling Regulates Hematopoiesis in a Dosage-Dependent Fashion Cell stem cell ·Tiago C. Luís, Brigitta A. E. Naber, Paul P.C. Roozen, Martijn H. Brugman, Edwin F. E. de Haas, Mehrnaz Ghazvini, Willem E. Fibbe, Jacques J. M. van Dongen, Riccardo Fodde, Frank J. T. Staal	2011	256
19	New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling The Journal of Experimental Medicine ·Willem A. Dik, Karin Pike‐Overzet, Floor Weerkamp, Dick de Ridder, Edwin F. E. de Haas, Miranda R.M. Baert, Peter J. van der Spek, E. Koster, Marcel Reinders, Jacques J. M. van Dongen, Anton W. Langerak, Frank J. T. Staal	2005	247
20	Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age‐related changes and disease‐induced shifts Cytometry Part B Clinical Cytometry ·Ellen G. van Lochem, Vincent H. J. van der Velden, Henk Wind, Jeroen G. te Marvelde, N. A. C. Westerdaal, Jacques J. M. van Dongen	2004	243

About Jacques J. M. van Dongen

Jacques J. M. van Dongen is a scholar working on Immunology, Molecular Biology, Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 487 papers that have together received 26.2k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (110 papers), Immune Cell Function and Interaction (94 papers), T-cell and B-cell Immunology (92 papers), Chronic Lymphocytic Leukemia Research (87 papers), Immunodeficiency and Autoimmune Disorders (84 papers), Lymphoma Diagnosis and Treatment (73 papers), Acute Myeloid Leukemia Research (60 papers) and Monoclonal and Polyclonal Antibodies Research (44 papers). The work is most often cited by research in Hematology (8.3k citations), Immunology (8.6k citations), Genetics (3.8k citations), Public Health, Environmental and Occupational Health (6.3k citations) and Pathology and Forensic Medicine (3.6k citations). Jacques J. M. van Dongen has collaborated with scholars based in Netherlands, Spain and Germany. Frequent co-authors include Vincent H. J. van der Velden, Mirjam van der Burg, Anton W. Langerak, Menno C. van Zelm, Tomasz Szczepański, Alberto Órfão, Herbert Hooijkaas, Frank J. T. Staal, Giovanni Cazzaniga and Martie C. M. Verschuren. Their work appears in journals such as Blood, Leukemia, Frontiers in Immunology, The Journal of Immunology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Jacques J. M. van Dongen

Impact in

Papers in i

In The Last Decade

Jacques J. M. van Dongen

Jacques J. M. van Dongen's Hit Papers

Peers

Countries citing papers authored by Jacques J. M. van Dongen

Fields of papers citing papers by Jacques J. M. van Dongen

All Works

About Jacques J. M. van Dongen

Explore authors with similar magnitude of impact

Papers in